Genmab — Februar 2011
-
likviditeten er vist 116 mill bedre end de oplyser
-
jf. 32
-
skatteaktivet er svulmet til 1,3 mia
-
når man tager fabrikken ud og zalu ud og arzerra op ligger der 200 mill der og venter
-
de får da meget mere upfront i zalu
-
hvor fanden er jeres benchmarks henne drenge
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind